CPIX News and Press, Cumberland Pharmaceuticals Inc.

2026-03-03 19:33:17 ET More on Cumberland Pharmaceuticals Cumberland Pharmaceuticals Inc. (CPIX) Q4 2025 Earnings Call Prepared Remarks Transcript Seeking Alpha’s Quant Rating on Cumberland Pharmaceuticals Financial information for Cumberland Pharmaceuticals ...

2026-03-03 19:32:14 ET Cumberland Pharmaceuticals Inc. (CPIX) Q4 2025 Earnings Call March 3, 2026 4:30 PM EST... Read the full article on Seeking Alpha For further details see: Cumberland Pharmaceuticals Inc. (CPIX) Q4 2025 Earnings Call Prepared Remarks Transcript

2026-03-03 17:45:20 ET Image source: The Motley Fool. Tuesday, March 3, 2026 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-03-03 17:11:38 ET More on Cumberland Pharmaceuticals Seeking Alpha’s Quant Rating on Cumberland Pharmaceuticals Financial information for Cumberland Pharmaceuticals Read the full article on Seeking Alpha For further details see: Cumberland Pha...

CUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH PR Newswire Cumberland to highlight 2025 financial, international, portfolio and clinical progress NASHVILLE, Tenn. , March 3, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a spe...

2026-03-02 17:33:37 ET Cumberland Pharmaceuticals Inc. (CPIX) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in CPIX stock price following earnings has averaged ±5.23% , with a median of...

Joint U.S. Commercialization of RedHill's Talicia® Commences PR Newswire The full sales and operational launch of Talicia, under the joint commercialization agreement between Talicia Holdings Inc. (THI), a jointly controlled entity of RedHill and Cumberland has started and is ...

CUMBERLAND PHARMACEUTICALS LAUNCHES U.S. PROMOTION OF TALICIA® PR Newswire NASHVILLE, Tenn. , Feb. 25, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) , a specialty pharmaceutical company focused on developing new products for rare diseases, today a...

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE 2025 ANNUAL FINANCIAL RESULTS & COMPANY UPDATE CUMBERLAND PHARMACEUTICALS TO ANNOUNCE 2025 ANNUAL FINANCIAL RESULTS & COMPANY UPDATE PR Newswire NASHVILLE, Tenn. , Feb. 24, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nas...

2026-02-17 09:40:38 ET Short sellers are largely absent from a group of small- and mid-cap stocks where short interest hovers around just 0.5%, signaling limited bearish conviction across a diverse mix of sectors.... Read the full article on Seeking Alpha For further details see...